🎉 Health Canada Provides a No Objection Letter for ATMA’s N500 Phase II Clinical Trial Application

Read News

Bringing Integrative Healing to Psychedelic-Assisted Therapy

ATMA Provides A New View to Mental Healthcare

ATMA provides psychedelic therapy education and training to practitioners so you can offer this ground-breaking treatment to your mental health clients.

Subscribe to our newsletter
A means to incorporating Psychedelic Therapy

SUPPORTING YOUR PRACTICE AT EVERY STEP

Psychedelic-Assisted Therapy Training

Through the unique healing and transformative experiences of psychedelic-assisted therapy, we are witnessing a new frontier of treatment that is providing hope to those struggling with chronic, treatment resistant mental health concerns.

ATMA’s psychedelic therapy courses establish a standard of care for which mental health professionals should be trained to use psychedelics in their practice. Regulatory changes are occurring rapidly; healthcare professionals who achieve competency in this area will be uniquely positioned to adopt psychedelic therapy treatment into their practice immediately upon legalization of these medicines.

AS FEATURED ON

CBC, Canadian Broadcasting Company
The Globe and Mail
Calgary Herald
Truffle Report, psychedelics beneath the surface
CTV News

GET STARTED

Your Psychedelic Therapy Training Begins With Us

Globally renowned leaders in the medical community have partnered with ATMA to develop the curricula, training models, and lectures for the psychedelic therapy course offerings.
ATMA female student at her computer taking the Introduction to Psychedelic-Assisted Therapy training program

Introduction to Psychedelic-assisted Therapy

This course offers an overview of psychedelic medicines in a convenient manner, allowing for healthcare professionals to gain familiarity with psychedelic therapy medicine.

Learn more

Physicians and Prescribers Program

This is a CME eligible course for physicians, psychiatrists, and prescribers. It is important for prescribers to have knowledge, backed by science, to properly assess patients for psychedelic treatments.

Learn more
An instructor sitting with students for ATMA’s Advanced Psychedelic-assisted Therapy (PaT) Certification Program

Advanced Psychedelic-assisted Therapy (PaT) Certification Program

This program will provide the opportunity for legal experiential training under the supervision of skilled psychedelic guides and medical practitioners.

Learn more

ATMA ACADEMY ALUMNI

Meet our ATMA Academy Alumni from around the world

We’re proud to support mental health practitioners from around the world with our programs and initiatives. Learn how our students enjoyed learning with ATMA Academy.
"Great format of watching presentations ahead of time for the Q&A’s and then speaking to the amazing presenters about their experiences. Wonderful to connect with other therapists and interested individuals through breakout groups."
Maya Sloan, an ATMA psychedelic therapy training alumni
Maya Sloan
ATMA Alumni
"It’s wonderful to be on live Zoom calls with so many amazing teachers. Thank you all, so much gratitude for this space!"
Karolina Mikos
ATMA Alumni
"The richness of the experience, expertise and discussion was deeply meaningful. Thank you ATMA."
Alison Bell
ATMA Alumni
"So informative and a must if you are interested in becoming a psychedelic therapist."
Caroldean Jude, an ATMA psychedelic therapy training alumni
Caroldean Jude
ATMA Alumni
"This program has not only done a masterful job of setting the foundations for Psychedelic-assisted Therapy, but also helped connect participants with like-minded health providers and fostered a continued interest in exploring this needed healing modality at an even deeper level."
Mikael Bartholdy, an ATMA psychedelic therapy course alumni
Mikael Bartholdy
ATMA Alumni

OUR RESEARCH

Leading psilocybin therapy clinical trials and research

As part of our initiative to move psilocybin toward legalization, we are working with Health Canada to conduct multiple clinical trials evaluating its safety and efficacy. View our current clinical trials based in our Calgary, Alberta office.
View trials

Blog

Our blogs explore informative and relevant topics on psychedelic medicine.

Read Blog

News & Media

The latest news and media releases on ATMA and our contributions.

Read News

Oregon Services

Learn more on how Oregon is accelerating psilocybin-assisted therapy for practitioners.

Learn more

Psychedelic Exposé

Our free monthly webinars cover a variety of topics within the psychedelic landscape.

Learn more

ONGOING SUPPORT

Building the largest online community for psychedelic therapy

Our online community platform connects you with like-minded peers, the latest research on psychedelics, exclusive discounts and events, and more. Join our community when you register for our training programs. 

Learn more

BE THE FIRST TO KNOW

Stay informed on ATMA's various initiatives and offerings in psychedelic therapy

ATMA, psychedelic training white logo

2303 4 St SW, T2S 2S7
Calgary, Alberta, Canada

Facebook Twitter Instagram Linkedin

Company

Training

Resources

Dr. Megan McElheran is the CEO and Chief Clinical Psychologist of Wayfound Mental Health Group. Dr. McElheran completed graduate training at the PAU-Stanford University Clinical Psychology Consortium, during which she obtained specialized training in the treatment of PTSD through the National Center for PTSD in Menlo Park, CA. Dr. McElheran has been in practice in Calgary since 2008. She continues to focus on work with first responders, and her clinical practice involves work with active-duty members of the Canadian Forces, members of the Royal Canadian Mounted Police, members of the Calgary Firefighter Department, medical personnel, and others who are directly or vicariously impacted by traumatic events. She routinely engages in teaching and supervisory activity to ensure the sound dissemination of empirically-grounded interventions for trauma. Dr. McElheran is regularly engaged in speaking events, both locally and internationally. She completed a TEDx speech in 2011 related to Trauma, Change, and Resilience and most recently completed a discussion for the Healing Project on trauma and PTSD.

Dr. Anthony Bossis is a clinical psychologist and Clinical Assistant Professor of Psychiatry at New York University School of Medicine. He is Director of Palliative Care Research, Co-Principal Investigator, and a session guide for the NYU Psilocybin Cancer Anxiety Project, a FDA-approved clinical trial investigating the efficacy of a psilocybin-generated mystical experience upon existential and psycho-spiritual distress in persons with cancer.

Natalie has a deep passion for creating spaces for people to feel safe and open for personal transformation. Her experiences as an on-air radio personality, years as an on-air television journalist producing and directing a weekly show as well as contributing to a daily live program for a national television station, allowed her to witness literally hundreds of peoples individual stories. In addition to these public roles, she managed multiple television station locations, designed and oversaw studio expansions, managed a program for artists and musicians with an international humanitarian organization, after which she started and ran her own successful company focused on personal health and wellness for 6 years.

David has worked full-time for the past 5 years in researching, advocating and moving the work of non-ordinary state therapy and psychedelic medicine forward in Canada. He co-founded and led Catalyst Presents, a Psychedelic Research Conference, and ATMA Journey Centers, a Canadian non-profit dedicated to bringing psychedelic-assisted therapy to Canadians which was successful in achieving one of Canada’s first modern legal exemptions to undertake psychedelic-assisted work. With a Master’s degree in religious studies and having been both a college professor and international humanitarian relief worker, David has always dedicated himself to the service of others. He brings a deep experience and reverence for psychedelic medicine and believes that it will play a key role in bringing healing to humanity.